Cargando…
Barriers and facilitators to recruitment and enrollment of HIV-infected individuals with opioid use disorder in a clinical trial
BACKGROUND: The CTN-0067 CHOICES trial tests implementation of extended-release naltrexone (XR-NTX) versus treatment-as-usual (TAU) for opioid use disorders (OUD) in HIV clinics to improve HIV viral suppression. The study team investigated recruitment strategies to elucidate the barriers and facilit...
Autores principales: | Hoffman, Kim A., Baker, Robin, Kunkel, Lynn E., Waddell, Elizabeth Needham, Lum, Paula J., McCarty, Dennis, Korthuis, P. Todd |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6868733/ https://www.ncbi.nlm.nih.gov/pubmed/31752905 http://dx.doi.org/10.1186/s12913-019-4721-x |
Ejemplares similares
-
Perspectives on extended-release naltrexone induction among patients living with HIV and opioid use disorder: a qualitative analysis
por: Hoffman, Kim A., et al.
Publicado: (2021) -
Use of single IRBs for multi-site studies: A case report and commentary from a National Drug Abuse Treatment Clinical Trials Network study
por: Nichols, Ceilidh, et al.
Publicado: (2019) -
Treatment and Prevention of Opioid Use Disorder: Challenges and Opportunities
por: McCarty, Dennis, et al.
Publicado: (2017) -
Recruitment challenges for a prospective telehealth cohort study
por: Pertl, Kellie, et al.
Publicado: (2022) -
HIV clinic‐based extended‐release naltrexone versus treatment as usual for people with HIV and opioid use disorder: a non‐blinded, randomized non‐inferiority trial
por: Korthuis, P. Todd, et al.
Publicado: (2022)